FDA Inspection
VitalantVitalant – FDA Inspection, Aug 29, 2025
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on August 29, 2025, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · ae29ad84-6e79-4024-92d2-f7c31489fdac
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1281750
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 12, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 7, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 21, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 28, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 18, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1167691 - 2022-04-12
- FDA Inspection 1037711 - 2017-12-07
- FDA Inspection 979707 - 2016-07-21
- FDA Inspection 871353 - 2014-02-28
- FDA Inspection 784588 - 2012-05-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.